Type of security: Stock
Sector: Health Care
Industry: Medical Specialities
The data is delayed by 15 minutes.
Description: Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. In addition, it provides molecular diagnostic products in various segments, such as HIV-1 drug resistance testing under the ViroSeq brand name; and reproductive genetics and transplantation under the
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||-95.95%||EPS Growth - Q/Q||-97.76%|
|EPS Growth - Y/Y||-46.52%||Sales Growth - 4 Quarters||-3.31%||Sales Growth - Q/Q||-2.34%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||4.83%||ROE||12.09%||ROI||6.04%|
|Current Ratio||1.14||Quick Ratio||1.09||Long Term Debt/Equity||12.9||Debt Ratio||0.49|
|Gross Margin||37.58%||Operating Margin||13.32%||Net Profit Margin||6.81%||Dividend Payout Ratio||-44.83%|
|Cash From Financing Activities||-246 M||Cash From Investing Activities||-123 M||Cash From Operating Activities||327 M||Gross Profit||747 M|
|Net Profit||118 M||Operating Profit||301 M||Total Assets||9.72 B||Total Current Assets||1.53 B|
|Total Current Liabilities||1.24 B||Total Debt||3.74 B||Total Liabilities||5.41 B||Total Revenue||1.93 B|
|High 52 week||106.88||Low 52 week||79.25||Last close||104.81||Last change||1.04%|
|RSI||48.81||Average true range||1.72||Beta||0.67||Volume||278.29 K|
|Simple moving average 20 days||-0.01%||Simple moving average 50 days||1.78%||Simple moving average 200 days||10.19%|
|Performance Week||2.61%||Performance Month||-0.31%||Performance Quart||5.17%||Performance Half||18.25%|
|Performance Year||5.21%||Performance Year-to-date||26.67%||Volatility daily||0.99%||Volatility weekly||2.22%|
|Volatility monthly||4.54%||Volatility yearly||15.74%||Relative Volume||285.51%||Average Volume||922.65 K|
|New High||New Low|
2019-11-03 08:59:44 | Is Quest Diagnostics Incorporated NYSE:DGX Trading At A 37% Discount?
2019-10-22 19:39:00 | Edited Transcript of DGX earnings conference call or presentation 22-Oct-19 12:30pm GMT
2019-10-22 11:44:03 | Quest Diagnostics DGX Q3 Earnings Surpass, View Strong
2019-10-22 06:45:00 | Quest Diagnostics Reports Third Quarter 2019 Financial Results
2019-10-22 06:30:00 | Quest Diagnostics, Inc. to Host Earnings Call
2019-10-18 18:52:30 | Were Hedge Funds Right About Warming Up To Quest Diagnostics DGX?
2019-10-17 12:03:04 | Will New Alliances Aid Quest Diagnostics DGX Q3 Earnings?
2019-10-16 06:44:44 | Is Quest Diagnostics NYSE:DGX A Risky Investment?
2019-10-11 18:14:34 | PHOTOS: Look inside the $30 million Dignity Health offices in Citrus Heights
2019-10-10 04:04:12 | 7 EBITDA Growth Stocks That Can Outperform in a Volatile Market
2019-10-08 10:36:02 | LabCorp LH Names Two Leaders for Major Business Wings
2019-10-04 15:35:00 | Quest Diagnostics To Release Third Quarter 2019 Financial Results On October 22
2019-10-02 11:25:03 | LabCorp to Expand Hematology Suite With Sysmex America Deal
2019-10-01 12:06:04 | Here's Why You Should Hold on to Quest Diagnostics Stock Now
2019-09-17 09:40:01 | DGX vs. ADUS: Which Stock Is the Better Value Option?
2019-09-17 09:10:01 | Is Quest Diagnostics DGX a Great Value Stock Right Now?
2019-09-11 09:10:01 | Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch
2019-09-11 09:00:01 | All You Need to Know About Quest Diagnostics DGX Rating Upgrade to Buy
2019-09-10 16:02:00 | Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader
2019-08-30 08:46:55 | Is It Too Late To Consider Buying Quest Diagnostics Incorporated NYSE:DGX?
2019-08-29 09:56:01 | Quest Diagnostics' New Acquisitions and Pacts Aid Growth
2019-08-28 16:41:00 | Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
2019-08-28 06:29:25 | LabCorp joins in $17.5M round for Cambridge diagnostic startup Boston Microfluidics
2019-08-23 14:14:00 | Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference
2019-08-22 09:30:01 | Why Is Quest Diagnostics DGX Down 0.2% Since Last Earnings Report?
2019-08-20 09:50:01 | Should Value Investors Pick Quest Diagnostics DGX Stock?
2019-08-16 08:53:12 | Outlook for Outpatient and Home Healthcare Industry Looks Bright
2019-08-15 17:27:26 | Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future
2019-08-15 06:45:00 | Quest Diagnostics Declares Quarterly Cash Dividend
2019-08-13 18:35:47 | Chris Davis Buys 3 Stocks in 2nd Quarter
2019-08-06 15:23:33 | Oxford Immunotec Global PLC OXFD Q2 2019 Earnings Call Transcript
2019-07-26 09:30:01 | DGX vs. LHCG: Which Stock Is the Better Value Option?
2019-07-24 08:38:28 | Is Quest Diagnostics Incorporated NYSE:DGX Better Than Average At Deploying Capital?
2019-07-23 22:18:17 | Edited Transcript of DGX earnings conference call or presentation 23-Jul-19 12:30pm GMT
2019-07-23 15:00:00 | What You Need to Know About Quest Diagnostics' Q2 Earnings Results
2019-07-23 09:50:01 | Quest Diagnostics DGX Q2 Earnings, Revenues Beat Estimates
2019-07-23 06:58:00 | Quest Diagnostics Shares Surge After Healthy Quarterly Results
2019-07-23 06:45:00 | Quest Diagnostics Reports Second Quarter 2019 Financial Results
2019-07-23 06:30:00 | Quest Diagnostics, Inc. to Host Earnings Call